Cleared Traditional

MagnetOs Putty (K181958) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K181958 · Kuros Biosciences B.V · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
136d
Days
Class 2
Risk

K181958 is an FDA 510(k) clearance for the MagnetOs Putty. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Kuros Biosciences B.V (Bilthoven, NL). The FDA issued a Cleared decision on December 6, 2018 after a review of 136 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Kuros Biosciences B.V devices

Submission Details

510(k) Number K181958 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2018
Decision Date December 06, 2018
Days to Decision 136 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 122d · This submission: 136d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Compliance Solutions, Ltd.
Angela Paterson

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 201
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K181958.
Mineral Collagen Composite Bioactive Moldable
K182074 · Collagen Matrix, Inc. · Mar 2019
PROSTIM Injectable Inductive Graft
K190283 · Wrightmedicaltechnologyinc · Mar 2019
FIBERGRAFT AERIDYAN Matrix Bone Graft Substitute
K182670 · Prosidyan, Inc. · Dec 2018
PRODENSE Bone Graft Substitute
K182823 · Wrightmedicaltechnologyinc · Nov 2018
Osteocera Resorbable Bone Substitute
K180758 · Wiltrom Corporation Limited · Oct 2018
Ceracell Ortho Foam
K181721 · Curasan AG · Sep 2018